TY - JOUR
T1 - Comparison of different methods of thrombus permeability measurement and impact on recanalization in the INTERRSeCT multinational multicenter prospective cohort study
AU - On behalf of the INTERRSeCT Investigators
AU - Gensicke, Henrik
AU - Evans, James W.
AU - Al Ajlan, Fahad S.
AU - Dowlatshahi, Dar
AU - Najm, Mohamed
AU - Calleja, Ana L.
AU - Puig, Josep
AU - Sohn, Sung l.I.
AU - Ahn, Seong H.
AU - Poppe, Alexandre Y.
AU - Mikulik, Robert
AU - Asdaghi, Negar
AU - Field, Thalia S.
AU - Jin, Albert
AU - Asil, Talip
AU - Boulanger, Jean Martin
AU - Hill, Michael D.
AU - Goyal, Mayank
AU - Demchuk, Andrew M.
AU - Menon, Bijoy K.
N1 - Funding Information:
Henrik Gensicke has received research support from the Swiss National Science Foundation. James W Evans, Fahad S. Al Ajlan, Dar Dowlatshah, Mohamed Najm, Ana L. Calleja, Josep Puid, Sung-lI Sohn, Seong H. Ahn, Alexandre Y Poppe, Negar Asdaghi, Albert Jin, Talip Asil, and Jean-Martin Boulanger declare that they have no conflict of interest. Robert Mikulik has been supported by the project no. LQ1605 from the National Program of Sustainability II (MEYS CR). Thalia S. Field has received research support from the Canadian Institutes of Health Research, the Michael Smith Foundation for Health Research, the Heart and Stroke Foundation of Canada, the Vancouver Coastal Health Research Institute, and Bayer Canada (study medication). Michael D. Hill is supported by the Heart & Stroke Foundation of Alberta-Hotchkiss Brain Institute Professorship in Stroke Research. Mayank Goyal has received consulting fees from Medtronic, Stryker, and Microvention and holds a patent on a system of acute stroke diagnosis licensed to GE Healthcare. Andrew M. Demchuk has received honoraria from Medtronic for CME events. He also received operational grant funding from the Canadian Institute for Health Research for the INTERRSeCT study. Bijoy K. Menon holds the Heart and Stroke Foundation Professorship in Stroke Imaging and has received operational grant funding from the Canadian Institute of Health Research.
Funding Information:
This study was supported by an operating grant from the Canadian Institutes of Health Research and by a grant from the Swiss National Foundation (P300PB_161071).
Publisher Copyright:
© 2019, Springer-Verlag GmbH Germany, part of Springer Nature.
PY - 2020/3/1
Y1 - 2020/3/1
N2 - Purpose: To compare the association of different measures of intracranial thrombus permeability on non-contrast computerized tomography (NCCT) and computed tomography angiography (CTA) with recanalization with or without intravenous alteplase. Methods: Patients with anterior circulation occlusion from the INTERRSeCT study were included. Thrombus permeability was measured on non-contrast CT and CTA using the following methods: [1] automated method, mean attenuation increase on co-registered thin (< 2.5 mm) CTA/NCCT; [2] semi-automated method, maximum attenuation increase on non-registered CTA/NCCT (ΔHUmax); [3] manual method, maximum attenuation on CTA (HUmax); and [4] visual method, residual flow grade. Primary outcome was recanalization with intravenous alteplase on the revised AOL scale (2b/3). Regression models were compared using C-statistic, Akaike (AIC), and Bayesian information criterion (BIC). Results: Four hundred eighty patients were included in this analysis. Statistical models using methods 2, 3, and 4 were similar in their ability to discriminate recanalizers from non-recanalizers (C-statistic 0.667, 0.683, and 0.634, respectively); method 3 had the least information loss (AIC = 483.8; BIC = 492.2). A HUmax ≥ 89 measured with method 3 provided optimal sensitivity and specificity in discriminating recanalizers from non-recanalizers [recanalization 55.4% (95%CI 46.2–64.6) when HUmax > 89 vs. 16.8% (95%CI 13.0–20.6) when HUmax ≤ 89]. In sensitivity analyses restricted to patients with co-registered CTA/NCCT (n = 88), methods 1–4 predicted recanalization similarly (C-statistic 0.641, 0.688, 0.640, 0.648, respectively) with Method 2 having the least information loss (AIC 104.8, BIC 109.8). Conclusion: Simple methods that measure thrombus permeability are as reliable as complex image processing methods in discriminating recanalizers from non-recanalizers.
AB - Purpose: To compare the association of different measures of intracranial thrombus permeability on non-contrast computerized tomography (NCCT) and computed tomography angiography (CTA) with recanalization with or without intravenous alteplase. Methods: Patients with anterior circulation occlusion from the INTERRSeCT study were included. Thrombus permeability was measured on non-contrast CT and CTA using the following methods: [1] automated method, mean attenuation increase on co-registered thin (< 2.5 mm) CTA/NCCT; [2] semi-automated method, maximum attenuation increase on non-registered CTA/NCCT (ΔHUmax); [3] manual method, maximum attenuation on CTA (HUmax); and [4] visual method, residual flow grade. Primary outcome was recanalization with intravenous alteplase on the revised AOL scale (2b/3). Regression models were compared using C-statistic, Akaike (AIC), and Bayesian information criterion (BIC). Results: Four hundred eighty patients were included in this analysis. Statistical models using methods 2, 3, and 4 were similar in their ability to discriminate recanalizers from non-recanalizers (C-statistic 0.667, 0.683, and 0.634, respectively); method 3 had the least information loss (AIC = 483.8; BIC = 492.2). A HUmax ≥ 89 measured with method 3 provided optimal sensitivity and specificity in discriminating recanalizers from non-recanalizers [recanalization 55.4% (95%CI 46.2–64.6) when HUmax > 89 vs. 16.8% (95%CI 13.0–20.6) when HUmax ≤ 89]. In sensitivity analyses restricted to patients with co-registered CTA/NCCT (n = 88), methods 1–4 predicted recanalization similarly (C-statistic 0.641, 0.688, 0.640, 0.648, respectively) with Method 2 having the least information loss (AIC 104.8, BIC 109.8). Conclusion: Simple methods that measure thrombus permeability are as reliable as complex image processing methods in discriminating recanalizers from non-recanalizers.
KW - Acute ischemic stroke
KW - CTA
KW - NCCT
KW - Recanalization therapies
KW - Thrombus permeability
UR - http://www.scopus.com/inward/record.url?scp=85075197282&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85075197282&partnerID=8YFLogxK
U2 - 10.1007/s00234-019-02320-y
DO - 10.1007/s00234-019-02320-y
M3 - Article
C2 - 31713667
AN - SCOPUS:85075197282
VL - 62
SP - 301
EP - 306
JO - Neuroradiology
JF - Neuroradiology
SN - 0028-3940
IS - 3
ER -